2024 Episode 13 – Heart Failure, Chronic Kidney Disease, and Type 2 Diabetes

Listen to Katherine R. Tuttle, MD, FASN, FACP, FNKF, Anthony Good, DNP, MBA, FNP-BC, GNP-BC, andJoshua J. Neumiller, PharmD, CDCES, FASCP, FADCES discuss the prevalence of heart failure, chronic kidney disease, type 2 diabetes and the impact these conditions have on patient outcomes. Management options to mitigate these risks, current guidelines and diagnostic practices will also be discussed.

Play the podcast in Apple Podcasts.

podcast player graphic

2024 Episode 13 – Heart Failure, Chronic Kidney Disease, and Type 2 Diabetes

2024 Episode 13 – Heart Failure, Chronic Kidney Disease, and Type 2 Diabetes Transcript

Katherine R. Tuttle, MD, FASN, FACP, FNKF is Executive Director for Research at Providence Inland Northwest Health, Regional Principal Investigator of the Institute of Translational Health Sciences and Professor of Medicine at the University of Washington. Dr. Tuttle’s major research interests are in diabetes and chronic kidney with over 350 original peer-reviewed publications. She leads the Center for Kidney Disease Research, Education and Hope (CURE-CKD) Registry of real-world data for chronic kidney disease, diabetes, prediabetes, and hypertension from over 5 million health system patients. Dr. Tuttle is also Chair of the Diabetic Kidney Disease Collaborative for the American Society of Nephrology.

Anthony Good, DNP, MSN, MBA, APRN, FNP-BC, GNP-BC, RN joined the faculty at St. Francis in 2021 as the Program Director, MSN Family (Individual Across the Lifespan) Nurse Practitioner and Program Director Family (Individual Across the Lifespan) Post-Master’s Certificate. He has practiced as a nurse practitioner in primary care, urgent care and nephrology. He continues to maintain active practice at Advanced Kidney Care Medical Associates, Pittsburgh, Pennsylvania. He has been a faculty member for more than 10 years and his research interests include simulation, quality of life and care satisfaction.

Joshua J. Neumiller, PharmD, CDCES, FASCP, FADCES is the Allen I. White Distinguished Professor in the College of Pharmacy and Pharmaceutical Sciences at Washington State University (WSU). He served as Chair of the ADA’s (American Diabetes Association) Professional Practice Committee from 2018-2019, whose primary responsibility is updating the ADA’s Standards of Care in Diabetes each year. Josh is currently President Elect for Health Care & Education at ADA and is co-Editor for the ADA’s Guide to Medications for the Treatment of Diabetes Mellitus. In addition to his work at WSU, Josh holds a research appointment with Providence Medical Research Center in Spokane, Washington and is an investigator with the Center for Kidney Disease Research, Education and Hope (CURE-CKD).